Verwendung von (S)(+)-2-Äthoxy-4-[N-[1-(2-Piperidino-Phenyl)-3-Methyl-1-Butyl[Aminocarbonylmethyl]-Benzoesäure zur Herstellung eines Langzeitantidiabetikums

(S)(+)-2-ethoxy-4-(N-1- (2-piperidino-phenyl)- 3-methyl-1-butyl) aminocarbonylmethyl)- benzoic acid (I), and its salts, are new. The intermediate (S)-3-methyl-1- (2-piperdine-phenyl) -1-butylamine (II) and its amide intermediates of formulae (III), (IV) and (VII) are also new. E.g. (either R = Et an...

Full description

Saved in:
Bibliographic Details
Main Authors GREISCHEL ANDREAS, MARK MICHAEL, KNORR HANSJOERG, GRELL WOLFGANG, MUELLER UELRICH, ZAHN GABRIELE, RUPPRECHT ECKHARD
Format Patent
LanguageGerman
Published 08.01.2004
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:(S)(+)-2-ethoxy-4-(N-1- (2-piperidino-phenyl)- 3-methyl-1-butyl) aminocarbonylmethyl)- benzoic acid (I), and its salts, are new. The intermediate (S)-3-methyl-1- (2-piperdine-phenyl) -1-butylamine (II) and its amide intermediates of formulae (III), (IV) and (VII) are also new. E.g. (either R = Et and A = gp. which can be hydrolysed, thermolysed, hydrogenated or oxidised to carboxy; or R=H and A = carboxy or 1-4C alkyoxy - carbonyl (opt. alkyl substd. by phenyl).
Bibliography:Application Number: DE20001075006C